1. Review the evolution of sacral neuromodulation
2. Explain the recent innovations and advancements in saral neuromodulation
3. Discuss the 2-year ARTISAN-SNM data

This webiner will review the evolution of sacral neuromodulationa and recent innovations and advancement in the therapy and the most recent clinical data.

Karen Noblett, MD MBA, serves as the Chief Medical Officer at Axonics, Board Certified in OB/GYN and Female Pelvic Medicine and Reconstructive Surgery and recently completed her MBA at the Paul Merage School of Business at UC Irvine. She previously served as the founding Chair and Professor of the Dept of OB/GYN in the School of Medicine at the University of California, Riverside from 2014-2017. Prior to this, she was a Professor in the OB/GYN Dept and Fellowship and Division Director for Urogynecology at the University of California, Irvine, as well serving as the Interim Chief Medical Officer. Dr. Noblett has also served on the American Board of OB/GYN Board of Directors and the American Urogynecology Board of Directors and maintains an academic appointment at UC Irvine in the dept of OB/GYN, division of Female Pelvic Medicine and Reconstructive Surgery. She has published over 50 peer-reviewed journal articles and authored multiple book chapters. She is a recognized expert in the field of Sacral Neuromodulation.